6th Edition of Addiction World Conference 2027
Scientific Sessions - AWC 2027
Opioid Use Disorder, Chronic Pain and MOUD
Opioid use disorder remains a leading cause of preventable death. This session reviews medications for opioid use disorder (buprenorphine, methadone, extended-release naltrexone), the challenge of treating chronic pain without fuelling dependence, and new approaches to tapering and pain management. It also addresses access barriers and retention in care.
Topics include: buprenorphine initiation and titration, methadone treatment, long-acting injectables, chronic pain and opioid tapering, cannabinoids in pain and OUD, retention in treatment.
Related Sessions
Miami 2027: The Global Epicenter of Addiction Science
The 6th Edition of the Addiction World Conference (AWC 2027) is officially arriving in Miami, FL, USA. From September ...
Read More>>
Organizer
